Tivic保健系统在2025年Q3收入增长12%,但由于研发支出增加,净亏损较大,同时保持全年收入前景。 Tivic Health Systems saw 12% revenue growth in Q3 2025 but reported a larger net loss due to higher R&D spending, while maintaining full-year revenue outlook.

Tivic卫生系统报告了2025年第三季度的财务结果,披露了1.42亿美元的收入,比去年同期增加了12%,原因是诊断成像产品的销售增加。 Tivic Health Systems reported third quarter 2025 financial results, disclosing revenue of $142 million, a 12% increase from the same period last year, driven by higher sales of its diagnostic imaging products. 该公司的净亏损为1 800万美元,而上一年季度亏损为1 400万美元,原因是研发费用增加。 The company posted a net loss of $18 million, compared to a $14 million loss in the prior-year quarter, citing increased research and development expenses. Tivic维持其2025年全年收入指导,预计总收入在5.6亿至5.75亿美元之间。 Tivic maintained its full-year 2025 revenue guidance, expecting total revenue between $560 million and $575 million.